After conception, the fetal neural tube (the future brain and spinal cord) closes at about 24-28 days.On the timeline above, that closing window is marked — it is early, and once it shuts, it stays shut.
Remember where this window sits; the next three steps all settle accounts on it: folate has to be in place before the door closes.
2 · Most people don't know yet
A missed period and a positive test usually land after the neural tube closing window, so folate has to start before pregnancy.Here is the catch: a missed period and a positive test usually land after the closing window. The 'you find out' marker on the timeline sits on the far side of the already-shut door.
So 'start folate at the first prenatal visit' is too late — the critical weeks are gone. The conclusion is blunt: folate is something to start before pregnancy, not after.
3 · Mechanism · folate is the methyl for DNA
Closing the neural tube depends on cells dividing very fast, each division copies DNA, and folate supplies the methyl groups needed to build that DNA.Why folate specifically? Closing the neural tube depends on cells dividing very fast, and every division must copy a full set of DNA. Folate's job is to supply the methyl groups needed to build that DNA.
Think of it as a methyl donor: enough methyl → cells divide cleanly → the tube closes on time. Too little, and the assembly line stalls in exactly those critical weeks.
4 · Dose guardrail · don't conflate the two
The general population is advised 400-800 micrograms a day; the 72% drop in recurrence came from high-risk women who already had an affected baby, taking 4 mg a day.Two numbers, two populations, don't mix them:
General population: 400-800 micrograms a day (the USPSTF's top-grade recommendation: high certainty of a substantial net benefit). This is the everyday amount for most people who could become pregnant.That often-quoted 72%: it comes from the landmark 1991 MRC and refers to high-risk women who already had a baby with a neural tube defect, using a high 4 mg/day dose, where recurrence risk fell 72% ( 0.28). Don't attach the 72% to the everyday 400 micrograms — the population (high-risk vs general) and the dose (4 mg vs micrograms) are both different. The 4 mg is a doctor-directed recurrence-prevention dose for high-risk people, not a reason for everyone to megadose.